Stay updated on Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov page continues to display a 403 Forbidden error, with an updated site revision identifier in the footer.
    Difference
    0.2%
    Check dated 2026-10-06T20:56:50.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The 403 error page content, including the HTML header and Home link, was removed from the page view. This indicates the error display is no longer shown for this page.
    Difference
    0.5%
    Check dated 2026-09-29T20:49:03.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the visible study content with an access-block screen, and shows a Home link to navigate back to the site.
    Difference
    20%
    Check dated 2026-09-22T22:24:41.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating a new version of the site; the available changes point to a backend or UI update rather than a modification of study content.
    Difference
    0.1%
    Check dated 2026-09-15T21:47:05.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page revision was bumped from v3.6.5 to v3.6.6, signaling an updated build of the ClinicalTrials.gov page. This maintenance update does not change the study information displayed.
    Difference
    0.1%
    Check dated 2026-09-01T18:12:22.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.4 to v3.6.5, indicating a site update. The study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-08-11T14:43:18.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.